Laboratory News and Research

RSS

New findings on Th17 cells pave way for human cancer treatment protocol

A recently identified immune cell that directs other cells to fight infection plays a critical role in regulating the immune system in both health and disease. Researchers from the University of Pennsylvania School of Medicine have discovered how a stimulatory molecule and a protein found on the membrane of another immune cell make T helper 17 cells multi-taskers of sorts. Th17 cells protect the body against infection and cancer, but are also culprits in some autoimmune diseases and out-of-control, cancerous cell growth.

29 Oct 2010

Prominent scientist in mitochondrial genetics joins Children's Hospital to establish CMEM

Douglas C. Wallace, Ph.D., a pioneer and internationally prominent scientist in the field of human mitochondrial genetics, has joined The Children's Hospital of Philadelphia to continue his investigations into the role of mitochondrial energy in health and disease.

29 Oct 2010

New iPSC cell lines could help in treating patients with lung diseases

A team of researchers from Boston University's Center for Regenerative Medicine and the Pulmonary Center have generated 100 new lines of human induced pluripotent stem cells (iPSC) from individuals with lung diseases, including cystic fibrosis and emphysema. The new stem cell lines could possibly lead to new treatments for these debilitating diseases.

29 Oct 2010

Researchers develop three-dimensional culture that mimics growth patterns of colon cancer stem cells

University of Pittsburgh researchers have devised a three-dimensional system in laboratory culture that mimics the growth patterns of colon cancer stem cells in patients. Their findings were presented at the American Association for Cancer Research special conference on Colorectal Cancer: Biology to Therapy, held Oct. 27-30, 2010.

29 Oct 2010

Caliper Life Sciences third quarter GAAP revenue decreases 8% to $29.7 million

Caliper Life Sciences, Inc., today reported results for its third quarter ended September 30, 2010. Third quarter GAAP revenue decreased 8% to $29.7 million from $32.2 million in the same period in 2009 as a result of divestitures in 2010 and 2009. Revenue from on-going business increased 10% on a reported basis and 11% on an organic basis.

28 Oct 2010

NeoGenomics third quarter revenue grows 19% to $8.7 million

NeoGenomics, Inc., a leading provider of cancer-focused genetic testing services today reported its results for the third quarter 2010.

28 Oct 2010

New computer program shows how brain's complex fiber tracks mature as we grow up

The brain's inner network becomes increasingly more efficient as humans mature. Now, for the first time without invasive measures, a joint study from the Ecole Polytechnique F-d-rale de Lausanne (EPFL) and the University of Lausanne (UNIL), in collaboration with Harvard Medical School, has verified these gains with a powerful new computer program. Reported in the PNAS early online edition last week, the soon-to-be-released software allows for individualized maps of vital brain connectivity that could aide in epilepsy and schizophrenia research.

28 Oct 2010

RExpert to discuss latest advancements in musculoskeletal bioengineering at NCKU International Symposium

The 4th International Symposium and Workshop on Virtual Interactive Musculoskeletal System, organized by National Cheng Kung University, Taiwanese Society of Biomechanics and Taiwanese Society of Biomechanics in Sports, is held on October 28th and 29th in International Conference Hall, Kuang-Fu Campus, National Cheng Kung University (NCKU), Tainan, Taiwan,

28 Oct 2010

Pharmasset's PSI-938 phase I monotherapy trial shows positive result for HCV treatment

Pharmasset, Inc. reported positive preliminary results today from its phase I monotherapy trial of PSI-352938 for the treatment of chronic hepatitis C (HCV). PSI-938 is a guanosine nucleotide analog polymerase inhibitor in development for the treatment of chronic HCV infection.

28 Oct 2010

World's largest research initiative to mutate all mouse genes

The world's largest research initiative to mutate all mouse genes is now able to reach the summit because the ambitious EUCOMMTOOLS project started on October 1, 2010. This project is being coordinated by Helmholtz Zentrum München and will finalize the groundwork for the analysis of all mouse gene functions. The findings will contribute to a better understanding of the pathogenesis of widespread diseases such as Alzheimer's, depression, diabetes, chronic lung diseases or cancer.

28 Oct 2010

AstraZeneca 2010 third quarter decreases 2% to $7,898 million

Anglo-Swedish pharmaceutical company AstraZeneca announced that revenue for the third quarter declined by 2% at constant exchange rates (CER) to $7,898 million.

28 Oct 2010

Scientists suggest FDA to reevaluate safety of plant-based antioxidants

Scientists are calling for more research on the possibility that some supposedly healthful plant-based antioxidants including those renowned for their apparent ability to prevent cancer may actually aggravate or even cause cancer in some individuals.

28 Oct 2010

Epigenomics presents data on Septin9 biomarker clinical study for colorectal cancer at UEGW

Epigenomics AG, the cancer diagnostics company, announced that new data obtained in a clinical study with the Company's proprietary Septin9 biomarker for the blood-based detection of colorectal cancer, were presented yesterday at the 18th United European Gastroenterology Week (UEGW) in Barcelona, Spain.

28 Oct 2010

IntegraGen to open subsidiary in Cambridge, Massachusetts

IntegraGen, Inc., a French biotechnology company dedicated to gene discovery and the development of molecular diagnostic products and services, announced today that it is expanding its operations by opening a U.S. subsidiary headquartered in Cambridge, Massachusetts that will support the company's clinical research initiatives focused on the early identification of children at risk of autism. IntegraGen will open the new office on November 1, 2010.

28 Oct 2010

Essential Pharmaceuticals to commence sales of cell media products acquired from Lifeblood Medical

Essential Pharmaceuticals, LLC, a private company dedicated to providing specialty reagents and solutions to the life sciences market, announced today that the Company will commence sales and distribution of three distinct animal-component-free products: serum replacement, cryopreservation and clinical pathology media, formerly sold under the LiforCell® name.

28 Oct 2010

Novartis to expand Cambridge global Research headquarters by 400,000 square feet

Novartis announced today that it will add 300 new jobs and invest $600 million over the next five years to expand its global Research headquarters campus on Massachusetts Avenue in Cambridge, Mass.

28 Oct 2010

New findings suggest way to treat lung diseases

A new study of an exotic, infectious virus that has caused three recent outbreaks in the United States reveals clues to how the virus might damage lungs during infection. The findings also suggest possible new ways to treat lung diseases in humans.

28 Oct 2010

TU/e researchers mimic process of bone formation in laboratory

Researchers at Eindhoven University of Technology (TU/e) have for the first time succeeded in mimicking the process of bone formation in the laboratory, and in visualizing the process in great detail. The results will be published in the December edition of the scientific journal Nature Materials.

28 Oct 2010

Flu deaths analyzed for future lessons

A new report has looked at all of England’s swine flu deaths in children under 18 during the 2009 pandemic. Researchers found that there was a higher risk of dying from the influenza A H1N1 strain of flu among certain groups of children, such as those with pre-existing conditions and those of a Pakistani or Bangladeshi background. However it was unclear why.

27 Oct 2010

NIH awards $12M over 3 years to promote diversity in scientific workforce

The National Institutes of Health has awarded six grants totaling approximately $12 million over three years through a new initiative aimed at fostering a diverse scientific workforce. The initiative, called the NIH Director's ARRA Funded Pathfinder Award to Promote Diversity in the Scientific Workforce, is funded through the American Recovery and Reinvestment Act (ARRA) and administered by NIH's National Institute of General Medical Sciences.

27 Oct 2010

Laboratory News and Research

New findings on Th17 cells pave way for human cancer treatment protocol

Prominent scientist in mitochondrial genetics joins Children's Hospital to establish CMEM

New iPSC cell lines could help in treating patients with lung diseases

Researchers develop three-dimensional culture that mimics growth patterns of colon cancer stem cells

Caliper Life Sciences third quarter GAAP revenue decreases 8% to $29.7 million

NeoGenomics third quarter revenue grows 19% to $8.7 million

New computer program shows how brain's complex fiber tracks mature as we grow up

RExpert to discuss latest advancements in musculoskeletal bioengineering at NCKU International Symposium

Pharmasset's PSI-938 phase I monotherapy trial shows positive result for HCV treatment

World's largest research initiative to mutate all mouse genes

AstraZeneca 2010 third quarter decreases 2% to $7,898 million

Scientists suggest FDA to reevaluate safety of plant-based antioxidants

Epigenomics presents data on Septin9 biomarker clinical study for colorectal cancer at UEGW

IntegraGen to open subsidiary in Cambridge, Massachusetts

Essential Pharmaceuticals to commence sales of cell media products acquired from Lifeblood Medical

Novartis to expand Cambridge global Research headquarters by 400,000 square feet

New findings suggest way to treat lung diseases

TU/e researchers mimic process of bone formation in laboratory

Flu deaths analyzed for future lessons

NIH awards $12M over 3 years to promote diversity in scientific workforce

Lab Diagnostics and Automation - Second Edition eBook

Revolutionizing Life Science: An Interview with SCIEX on ASMS, the SCIEX 7500+ System, and AI-Driven Quantitation

From Discovery Biology to ELRIG Chair

Breathing New Life into Diagnostics: Plasmion's SICRIT Technology

Latest Life Science News